Market Cap 1.44B
Revenue (ttm) 1.31B
Net Income (ttm) 132.42M
EPS (ttm) N/A
PE Ratio 10.50
Forward PE 10.58
Profit Margin 10.13%
Debt to Equity Ratio 0.88
Volume 344,200
Avg Vol 449,596
Day's Range N/A - N/A
Shares Out 30.96M
Stochastic %K 56%
Beta 1.14
Analysts Sell
Price Target $61.00

Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides suppor...

Industry: Medical Devices
Sector: Healthcare
Phone: 727 392 6464
Address:
11311 Concept Boulevard, Largo, United States
highnihilism
highnihilism Oct. 1 at 12:04 PM
$CBSH Commerce Bancshares Trades: 2 | Total $: 481 | 0.17 × 90-Day Avg $: 2.8 K | Call $: 481 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CNMD Conmed Trades: 3 | Total $: 600 | 0.04 × 90-Day Avg $: 14.1 K | Call $: 480 | Put $: 120 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CTS CTS Trades: 1 | Total $: 480 | 0.46 × 90-Day Avg $: 1.1 K | Call $: 480 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $PBA Pembina Pipeline Trades: 10 | Total $: 1.5 K | 0.21 × 90-Day Avg $: 7.1 K | Call $: 477 | Put $: 1 K | Single-Leg: 42% | Multi-Leg: 33% | Contingent: 25%
0 · Reply
TradingRunners
TradingRunners Sep. 23 at 9:11 AM
$CNMD Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
0 · Reply
lecorb
lecorb Sep. 22 at 1:26 PM
$CNMD F-1 Wait! The information in this prospectus is not complete and may be changed. The selling shareholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted. https://app.quotemedia.com/data/downloadFiling?webmasterId=500&ref=319460901&type=HTML&symbol=CMND&cdn=a429fd35d64a0bcd9328e07ad7190fa6&companyName=Clearmind+Medicine+Inc.&formType=F-1&formDescription=Registration+statement+for+securities+of+certain+foreign+private+issuers&dateFiled=2025-09-19
0 · Reply
Brandonchw
Brandonchw Sep. 17 at 3:08 PM
$CNMD I would like to wait under 50
0 · Reply
Brandonchw
Brandonchw Sep. 17 at 3:07 PM
$CNMD many robotic surgeries are using their products, e.g airseal, what do you guys think
0 · Reply
highnihilism
highnihilism Sep. 16 at 7:49 PM
IWM: Russell 2000 → $LQDT Liquidity Services $PRO Pros Holdings $CNMD Conmed $RPAY Repay $CWST Casella
0 · Reply
PivotRonnie
PivotRonnie Sep. 15 at 7:28 AM
$CNMD Short-term volatility likely; long-term hinges on margin expansion
0 · Reply
jdlman
jdlman Sep. 4 at 11:49 PM
0 · Reply
ZacksResearch
ZacksResearch Aug. 27 at 12:56 PM
$CNMD down 20% YTD — is a rebound on the horizon? 📈 Despite a challenging year, CONMED's strong recurring revenue base and promising growth in General Surgery signal potential upside. Their AirSeal product is a key contributor to General Surgery sales growth, used in 35-40% of procedures with Intuitive Surgical's da Vinci Xi system. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2743267/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2743267-body-9699&ADID=SYND_STOCKTWITS_TWEET_2_2743267_BODY_9699
0 · Reply
ZacksResearch
ZacksResearch Aug. 27 at 11:56 AM
$CNMD — Hold or fold? Here’s why it stays in the portfolio. AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle are driving growth, helping offset tariffs and supply risks. See the full bull/bear case here 👉 https://www.zacks.com/stock/news/2743267/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2743267-teaser-9697&ADID=SYND_STOCKTWITS_TWEET_2_2743267_TEASER_9697
0 · Reply
Latest News on CNMD
CONMED Corporation Announces Quarterly Cash Dividend

Aug 8, 2025, 7:00 AM EDT - 2 months ago

CONMED Corporation Announces Quarterly Cash Dividend


CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 10:48 PM EDT - 2 months ago

CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript


CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 9:52 PM EDT - 5 months ago

CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript


CONMED Corporation Adds Mark Kaye to its Board of Directors

Feb 25, 2025, 7:03 AM EST - 7 months ago

CONMED Corporation Adds Mark Kaye to its Board of Directors


These Analysts Slash Their Forecasts On Conmed After Q4 Results

Feb 6, 2025, 6:57 AM EST - 8 months ago

These Analysts Slash Their Forecasts On Conmed After Q4 Results


CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 7:05 PM EST - 8 months ago

CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript


Top 3 Health Care Stocks That May Dip This Month

Nov 25, 2024, 8:29 AM EST - 11 months ago

Top 3 Health Care Stocks That May Dip This Month

BFLY MDGL


CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:21 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript


CONMED Corporation Announces Leadership Succession

Oct 30, 2024, 4:02 PM EDT - 1 year ago

CONMED Corporation Announces Leadership Succession


CONMED Corporation (CNMD) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 10:33 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q2 2024 Earnings Call Transcript


CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript

Apr 25, 2024, 1:16 AM EDT - 1 year ago

CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript


CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript

Jan 31, 2024, 9:17 PM EST - 1 year ago

CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript


CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript

Oct 25, 2023, 8:18 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript


CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript

Jul 26, 2023, 11:03 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript


Conmed: Updated Guidance Is Positive

May 19, 2023, 3:06 PM EDT - 2 years ago

Conmed: Updated Guidance Is Positive


highnihilism
highnihilism Oct. 1 at 12:04 PM
$CBSH Commerce Bancshares Trades: 2 | Total $: 481 | 0.17 × 90-Day Avg $: 2.8 K | Call $: 481 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CNMD Conmed Trades: 3 | Total $: 600 | 0.04 × 90-Day Avg $: 14.1 K | Call $: 480 | Put $: 120 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CTS CTS Trades: 1 | Total $: 480 | 0.46 × 90-Day Avg $: 1.1 K | Call $: 480 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $PBA Pembina Pipeline Trades: 10 | Total $: 1.5 K | 0.21 × 90-Day Avg $: 7.1 K | Call $: 477 | Put $: 1 K | Single-Leg: 42% | Multi-Leg: 33% | Contingent: 25%
0 · Reply
TradingRunners
TradingRunners Sep. 23 at 9:11 AM
$CNMD Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
0 · Reply
lecorb
lecorb Sep. 22 at 1:26 PM
$CNMD F-1 Wait! The information in this prospectus is not complete and may be changed. The selling shareholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted. https://app.quotemedia.com/data/downloadFiling?webmasterId=500&ref=319460901&type=HTML&symbol=CMND&cdn=a429fd35d64a0bcd9328e07ad7190fa6&companyName=Clearmind+Medicine+Inc.&formType=F-1&formDescription=Registration+statement+for+securities+of+certain+foreign+private+issuers&dateFiled=2025-09-19
0 · Reply
Brandonchw
Brandonchw Sep. 17 at 3:08 PM
$CNMD I would like to wait under 50
0 · Reply
Brandonchw
Brandonchw Sep. 17 at 3:07 PM
$CNMD many robotic surgeries are using their products, e.g airseal, what do you guys think
0 · Reply
highnihilism
highnihilism Sep. 16 at 7:49 PM
IWM: Russell 2000 → $LQDT Liquidity Services $PRO Pros Holdings $CNMD Conmed $RPAY Repay $CWST Casella
0 · Reply
PivotRonnie
PivotRonnie Sep. 15 at 7:28 AM
$CNMD Short-term volatility likely; long-term hinges on margin expansion
0 · Reply
jdlman
jdlman Sep. 4 at 11:49 PM
0 · Reply
ZacksResearch
ZacksResearch Aug. 27 at 12:56 PM
$CNMD down 20% YTD — is a rebound on the horizon? 📈 Despite a challenging year, CONMED's strong recurring revenue base and promising growth in General Surgery signal potential upside. Their AirSeal product is a key contributor to General Surgery sales growth, used in 35-40% of procedures with Intuitive Surgical's da Vinci Xi system. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2743267/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2743267-body-9699&ADID=SYND_STOCKTWITS_TWEET_2_2743267_BODY_9699
0 · Reply
ZacksResearch
ZacksResearch Aug. 27 at 11:56 AM
$CNMD — Hold or fold? Here’s why it stays in the portfolio. AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle are driving growth, helping offset tariffs and supply risks. See the full bull/bear case here 👉 https://www.zacks.com/stock/news/2743267/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2743267-teaser-9697&ADID=SYND_STOCKTWITS_TWEET_2_2743267_TEASER_9697
0 · Reply
OnyxObelisk
OnyxObelisk Aug. 23 at 9:33 AM
$CNMD CONMED Corporation is facing medical device adoption challenges and competitive pressure
0 · Reply
JarvisFlow
JarvisFlow Aug. 19 at 10:00 AM
Stifel updates rating for Conmed ( $CNMD ) to Buy, target set at 76 → 72.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 10:00 AM
Wells Fargo updates rating for Conmed ( $CNMD ) to Equal-Weight, target set at 71 → 74.
0 · Reply
Estimize
Estimize Aug. 6 at 1:03 PM
Wall St is expecting 1.05 EPS for $CNMD Q3 [Reporting 10/22 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Jul. 31 at 6:42 PM
$CNMD beats expectations and raises 2025 guidance! 🚀 CONMED's Q2 adjusted EPS of $1.15 topped the Zacks Consensus Estimate, and revenues grew 3.1% year over year, driven by strong product momentum in BioBrace, AirSeal, and Foot & Ankle. The company now forecasts 2025 revenues up to $1.378 billion and adjusted EPS between $4.40-$4.55. Discover the full scoop here 👉 https://www.zacks.com/stock/news/2644986/conmed-q2-earnings-revenues-beat-estimates-2025-outlook-raised?cid=sm-stocktwits-2-2644986-body-5266&ADID=SYND_STOCKTWITS_TWEET_2_2644986_BODY_5266
0 · Reply
ZacksResearch
ZacksResearch Jul. 31 at 4:55 PM
$CNMD beat earnings and raised its 2025 outlook — what’s driving the upside? Q2 strength came from improving sales across both segments, pushing both earnings and revenues above estimates. Full breakdown here 👉 https://www.zacks.com/stock/news/2644986/conmed-q2-earnings-revenues-beat-estimates-2025-outlook-raised?cid=sm-stocktwits-2-2644986-teaser-5182&ADID=SYND_STOCKTWITS_TWEET_2_2644986_TEASER_5182
0 · Reply
JarvisFlow
JarvisFlow Jul. 31 at 1:56 PM
Piper Sandler updates rating for Conmed ( $CNMD ) to Overweight, target set at 80 → 68.
0 · Reply
DonCorleone77
DonCorleone77 Jul. 30 at 9:04 PM
$CNMD Conmed reports Q2 adjusted EPS $1.15, consensus $1.12 -- Q2 revenue $342.3M, consensus $338.42M. -- Cuts FY25 EPS view to $4.40-$4.55 from $4.45-$4.60, consensus $4.40 -- Narrows FY25 revenue view to $1.356B-$1.378B from $1.35B-$1.378B, consensus $1.36B.
0 · Reply
Estimize
Estimize Jul. 23 at 12:07 PM
Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
StockInsanity2025
StockInsanity2025 Jul. 21 at 5:08 PM
$CNMD reasonable price target anyone?
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 2:50 PM
$CNMD down 22.7% so far this year — is this medical player ready to bounce back? 📉 With a solid product lineup and improved margins, CONMED's 2025 outlook looks promising despite supply-chain and data security challenges. The company expects continued growth as hospital systems prioritize minimally invasive procedures. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-body-1180&ADID=SYND_STOCKTWITS_TWEET_2_2570795_BODY_1180
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 11:43 AM
$CNMD is holding strong — here’s why it still deserves a spot in your portfolio 👇 Recurring revenues are solid, margins are improving, and surgical product growth continues — even with supply and cybersecurity headwinds. Full breakdown here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2570795_TEASER
0 · Reply